The Lancet Respiratory Medicine in conversation with
A podcast by The Lancet Group
156 Episoade
-
Tuberculosis and the microbiome
Publicat: 03.09.2019 -
Antibiotics and non-severe exacerbations of bronchiectasis in children
Publicat: 16.08.2019 -
Use of extended-criteria donors for lung transplantation
Publicat: 06.08.2019 -
α1-antitrypsin deficiency testing
Publicat: 30.07.2019 -
Live-attenuated influenza vaccines in children
Publicat: 24.06.2019 -
Clearing the air on ambient air pollution
Publicat: 19.06.2019 -
A second look at FEAST
Publicat: 12.06.2019 -
Intensive care units and the USA
Publicat: 21.05.2019 -
A respiratory family affair
Publicat: 17.04.2019 -
A global approach to children's asthma
Publicat: 22.02.2019 -
The effectiveness of pleural manometry
Publicat: 14.02.2019 -
Lung volume reduction and emphysema
Publicat: 08.02.2019 -
Glimmers of hope for MDR-Tuberculosis treatment
Publicat: 08.01.2019 -
Effectiveness of flu vaccine over time
Publicat: 16.11.2018 -
Towards an International Pneumonia Network
Publicat: 12.11.2018 -
Laparoscopic anti-reflux surgery and IPF
Publicat: 02.11.2018 -
Improving the lives of patients with bronchiectasis
Publicat: 20.09.2018 -
Deep learning and fibrotic lung disease
Publicat: 17.09.2018 -
Critical care and infant nutrition
Publicat: 15.09.2018 -
Precision medicine in ARDS
Publicat: 03.08.2018
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
